Article thumbnail

APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

By Sigrid B Sando, Stacey Melquist, Ashley Cannon, Michael L Hutton, Olav Sletvold, Ingvild Saltvedt, Linda R White, Stian Lydersen and Jan O Aasly
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2375917
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1997). [Apolipoprotein E genotypes in patients investigated for dementia]. Ugeskr Laeger
  2. (1995). A: Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Bmj
  3. (1999). A: Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology
  4. (1993). Alberts MJ: Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology
  5. (2004). ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging
  6. (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet
  7. (2006). Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Arch Neurol
  8. (1995). Apolipoprotein E polymorphism and Alzheimer's disease in eastern Finland. Neurosci Lett
  9. (1993). Apolipoprotein E polymorphism and Alzheimer's disease. Lancet
  10. (1997). Apolipoprotein E type epsilon4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia. Clin Genet
  11. (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science
  12. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
  13. (2002). Apolipoprotein E4 and tau allele frequencies among Choctaw Indians. Neurosci Lett
  14. (1996). Bjertness E: Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort. Neurodegeneration
  15. (1994). Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet
  16. (1997). Didie r j e a n O , P e n e t C , M a r t i n C , P é r e z - T u r J , M i c h o n A , D u b o i s
  17. (2007). DM: Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease. Dement Geriatr Cogn Disord
  18. (2007). DW: Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.
  19. (1984). EM: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology
  20. (1992). Faergeman O: Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol
  21. (2004). Fratiglioni L: APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study. Arch Neurol
  22. (1996). Growdon JH: Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual. Arch Neurol
  23. (1981). Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. Biochemistry
  24. (1995). JL: Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both earlyand late-onset cases. Genet Epidemiol
  25. (2005). La Rue A: Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. J Geriatr Psychiatry Neurol
  26. (2006). Mastana SS: APOE distribution in world populations with new data from India and the UK. Ann Hum Biol
  27. (1994). Naruse S: ApoE-epsilon 4 and early-onset Alzheimer's. Nat Genet
  28. (2002). Non-familial Alzheimer's disease is mainly due to genetic factors.
  29. (1996). PA: Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology
  30. (1993). Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science
  31. (1975). PR: "Mini-Mental State": A practical method for grading the cognitive state of patients for clinician.
  32. (2004). Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex.
  33. (2002). SH: Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol
  34. (1996). The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet
  35. (1997). van Duijn CM: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA
  36. (2007). White LR: Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer's disease.